Beyond Barriers

A novel technology platform
for the delivery of therapeutics
across biological barriers

Gate2Brain

The solution

Gate2Brain
Technology

Gate2Brain (GB2) uses a novel technology platform for the delivery of therapeutics. Our platform is based on three families of peptide shuttles that improve the biopharmaceutical properties of cargoes such as small molecules, peptides, nanoparticles, proteins and antibodies in vitro and in vivo when conjugated to them.

The G2B technology platform is applicable to therapeutic areas in which biological barriers hinder the delivery and activity of drugs.

Read more

About us

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using a radically innovative peptide-based patented technology platform.

Technology

Gate2Brain (G2B) has a proprietary novel technology platform for the delivery of therapeutics across biological barriers.

Medicines beyond barriers

We go beyond physiological and disease barriers, as our portfolio of peptide shuttles cover barriers such as the blood-brain,
blood-retinal, skin and tumor barriers.
We go beyond economic barriers, such as the lack of investment for the development of pediatric drugs. We go beyond societal barriers to provide medicines for everyone, everywhere.

Clinical Focus

Therapeutic
Proof of Concept

Our G2B therapeutic-peptide shuttle conjugates carry the drug cargo candidates to the target site in which the disease arises. G2B-002, our flagship product and proof-of-concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancers.

Our objective is for G2B-002 to reach Phase 1 clinical trials and thus have a high social impact focused on the unmet medical needs of:

Rare illnesses
Pediatric patients
Oncologic diseases

G2B-002 shows potent preclinical activity for rare pediatric cancer indications such as pediatric high-grade gliomas, DIPG, Ewing sarcoma, rhabdomyosarcoma and neuroblastoma.

  • Gate2Brain
  • Gate2Brain
  • Gate2Brain

News & Media

Welcome to our news section, which provides a selection of our coverage in the media, industry, latest developments, plus videos, and more.

Meritxell Teixidó això de semblar una superwomen em patina moltDiari Ara

I couldn’t care less about looking like a “superwoman”

Meritxell Teixidó I couldn't care less about looking like a "superwoman" CEO & CO-FOUNDER OF…
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansión

THIS IS HOW A DRUG IS TOWED TO THE BRAIN

Sometimes drugs need a special push to be more effective and reach its final destination: the brain.…
Womenstartupawardsgate2Brain

WomenStarUpAwards

Meritxell Teixido, CEO/ CSO of Gate2Brain, won the #WomenStartupAwards in the “Inspiration category”. During…
Grit International Female Accelerator!Grit International Female Accelerator

G2B joined the Grit International Female Accelerator

Gate2Brain has been selected to be part of the 2022 cohort of the Grit International Female Accelerator. This…
Biotech New Frontiers Award 2022Gate2Brain

G2B awarded with Biotech New Frontiers 2022

Gate2Brain award with Biotech New Frontiers 2022 Gate2Brain attended the 5th Congress of Medical Biotechnology…
Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelona

Gate2Brain attends the 1st edition of the University of Barcelona spin-offs “Cockroaches vs Unicorns”

Gate2Brain attends the 1st edition of the University of Barcelona spin-offs gathering “Cockroaches vs…
Gate2Brain obtains the Innovative SME seal This seal, awarded by the Ministry of Science and Innovation of Spain, recognizes companies that carry out activities in the field of research, technological development and innovation.Gate2Brain

Gate2Brain obtains Innovative SME seal

Gate2Brain obtains the Innovative SME seal. This seal, awarded by the Ministry of Science and Innovation…
The Barcelona Deep Tech Award is part of the Barcelona Deep Tech Node initiative, which aims to support deep tech startups and spin-offs by facilitating their access to the market and international projection 🌐 and fostering the Deep Tech ecosystem in Barcelona.Barcelona Activa

Gate2Brain finalist in the Barcelona Deep Tech Award

,
Gate2Brain has been selected finalist in the Barcelona Deep Tech Awards together with the four startups:…
internship Eada

EADA Master students at Gate2Brain

As part of their International Master in Management and International Master in Pharmaceutical and Biotechnology…

1
2
Gate2Brain
1

Making therapies a reality for patients by addressing unmet medical needs.

2

Improving patients’ quality of life using a technology that provides superior drug transport efficacy.

Go Beyond Barriers & Contact Us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain